DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
178 hedge funds and large institutions have $1.24B invested in DIPLOMAT PHARMACY, INC. in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 84 increasing their positions, 49 reducing their positions, and 46 closing their positions.
72% more call options, than puts
Call options by funds: $3.3M | Put options by funds: $1.92M
71% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 49
14% less funds holding
Funds holding: 206 → 178 (-28)
20% less capital invested
Capital invested by funds: $1.54B → $1.24B (-$305M)
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
57% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$109M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$34.4M |
| 3 |
BlackRock
New York
|
+$26.2M |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$22M |
| 5 |
DM
Deerfield Management
New York
|
+$18.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$62.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$43.9M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$31.7M |
| 4 |
RI
Redwood Investments
Boston,
Massachusetts
|
-$20M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$15.7M |
DPLO Hedge Fund Activity: Q3 2018 in Review
178 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q3 2018, worth a combined $1.24B — down 20% from $1.54B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of DPLO and 20 opened new positions — a net loss of 26 holders — while 49 trimmed existing stakes and 84 added.
The largest buyer was Capital International Investors, opening a new position worth an estimated $109M. The largest seller was Capital World Investors, cutting an estimated $62.2M.
- 178 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q3 2018, down from 206 in Q2 2018.
- Funds reported $1.24B of DIPLOMAT PHARMACY, INC. stock for Q3 2018, down 20% quarter-over-quarter.
- 20 funds opened new DIPLOMAT PHARMACY, INC. positions in Q3 2018 and 46 closed out, a net change of -26 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q3 2018 was Capital International Investors, an estimated $109M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q3 2018 was Capital World Investors, an estimated $62.2M sold.
Based on aggregated 13F filings for Q3 2018.